Literature DB >> 10839665

Emergence of zidovudine resistance in HIV-infected patients receiving stavudine.

C de Mendoza, V Soriano, C Briones, O Gallego, P Barreiro, A Alvarez, J González-Lahoz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10839665     DOI： 10.1097/00126334-200003010-00013

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  6 in total

Review 1.  Stavudine once daily.

Authors:  Susan M Cheer; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Changes in the human immunodeficiency virus p7-p1-p6 gag gene in drug-naive and pretreated patients.

Authors:  Oscar Gallego; Carmen de Mendoza; Angélica Corral; Vincent Soriano
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  Differential removal of thymidine nucleotide analogues from blocked DNA chains by human immunodeficiency virus reverse transcriptase in the presence of physiological concentrations of 2'-deoxynucleoside triphosphates.

Authors:  P R Meyer; S E Matsuura; R F Schinazi; A G So; W A Scott
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

4.  A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation.

Authors:  J Gerardo García-Lerma; Hamish MacInnes; Diane Bennett; Patrick Reid; Soumya Nidtha; Hillard Weinstock; Jonathan E Kaplan; Walid Heneine
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.

Authors:  Christian T Ruff; Stuart C Ray; Patricia Kwon; Rebekah Zinn; Amanda Pendleton; Nancy Hutton; Roxann Ashworth; Stephen Gange; Thomas C Quinn; Robert F Siliciano; Deborah Persaud
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

6.  ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase.

Authors:  Lisa K Naeger; Nicolas A Margot; Michael D Miller
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.